• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Vascular Solutions legal updates: We’re ready to fight, CEO says

Vascular Solutions legal updates: We’re ready to fight, CEO says

July 26, 2013 By Arezu Sarvestani

Vascular Solutions legal updates: We're ready to fight, CEO says

New Jersey medical device maker Vascular Solutions (NSDQ:VASC) has been fighting patent infringement battles on a couple of fronts, and the company is ready to go the distance to protect its portfolio.

In its latest financial report, Vascular Solutions provided updates on patent battles against Boston Scientific (NYSE:BSX) and Terumo Corp. (TYO:4543) over catheter and compression system technologies, respectively.

Vascular Solutions CEO Howard Root was bullish about the company’s prospects in a recent call with investors, noting that it expects a decision this August in a lawsuit accusing Boston Scientific and its Guidezilla catheter of patent infringement.

Root has previously called Guidezilla "one of the most blatant plagiarisms of a patented medical device that I have ever encountered."

The lawsuit alleges that Boston Scientific’s Guidezilla catheter "is a copy of VSIs GuideLiner catheter. Guidezilla’s design, materials, and dimensions are materially the same as those of GuideLiner and those described and claimed in the patents-in-suit," according to court documents.

Vascular Solutions had attempted to win a court injunction preventing Boston Scientific from manufacturing or selling Guidezilla in the U.S., but Boston Scientific earlier this month touted regulatory wins in the U.S., the E.U. and in Japan and said launches would begin immediately.

Boston Scientific also field a counterclaim, accusing Vascular Solutions and its GuideLiner catheter of violating a Boston Scientific patent that recently expired, according to Vascular Solutions’ report. Boston Scientific filed the claim on July 11, asking the court to award unspecified damages as well as legal fees.

"Without going into litigation details, we believe that this is a clear case of patents and the copyright infringement that should be subject to an injunction stopping sale and use of Guidezilla," Root said during an earnings call this week. "However, rulings of patent litigation are always unpredictable. So we are also prepared to compete against what might become our 1st ever competition for GuideLiner."

GuideLiner is currently Vascular Solutions’ 2nd-highest selling product, Root noted.

Vascular Solutions is also the subject of a lawsuit filed by Terumo, which accused Vascular Solutions of violating both patent and trademark rights with the R-Band radial compression device. Terumo claimed that the Vascular Solutions’ R-Band is a trademark violation of Terumo’s TR-Band and that the device violates Terumo’s product patents.

Terumo in March asked a court to issue an injunction preventing Vascular Solutions from selling R-Band, and in May Vascular Solutions agreed, without admitting any wrongdoing, to stop selling R-Band during the course of the lawsuit. The concession came shortly after Vascular Solutions introduced its Vasc Band product.

Filed Under: Catheters, Legal News, News Well, Patent Infringement Tagged With: Boston Scientific, Minnesota, vascularsolutions

More recent news

  • Data backs DermaSensor skin cancer detection device
  • GE HealthCare expands digital imaging portfolio with enhanced MIM Encore software
  • Accelus wins FDA clearance for MRI compatibility of FlareHawk spinal implants
  • Presidio wins FDA IDE for ultra-low frequency neuromod, hires new CFO
  • Epiminder study backs implantable EEG tech

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy